Skip to main content
Sadhana Nitrochem Ltd. logo

Sadhana Nitrochem Ltd. — Investor Relations & Filings

Ticker · SADHNANIQ ISIN · INE888C01040 BSE.NS Manufacturing
Open in API
Filings indexed 835 across all filing types
Latest filing 2026-02-10 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS SADHNANIQ

About Sadhana Nitrochem Ltd.

https://www.sncl.com

Sadhana Nitrochem Ltd. specializes in the manufacture of chemical intermediates and performance chemicals. The company's core product portfolio includes nitrobenzene and its downstream derivatives such as metanilic acid, aniline 2,5 disulphonic acid, and sodium meta nitrobenzene sulphonate. These products serve as critical raw materials for the global dyes, pigments, pharmaceuticals, and agrochemicals sectors. The company operates advanced manufacturing facilities focused on high-purity chemical synthesis and process optimization. Its technical capabilities extend to specialized chemical reactions including nitration, hydrogenation, and sulfonation. By maintaining a vertically integrated production model, the company ensures consistent quality and supply chain reliability for its international client base across various industrial applications.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a filing under SEBI (LODR) Regulation 30 announcing the outcome of a board meeting, including approval of unaudited standalone & consolidated financial results for the quarter and nine months ended December 31, 2025. It contains the full interim financial statements (income, expenses, comprehensive income, earnings per share), plus an auditor’s limited review report under Ind AS 34/SRE 2410. This aligns with an Interim/Quarterly Report rather than a mere earnings release or annual report. Therefore, it should be classified as an Interim / Quarterly Report (IR). 9M 2025
2026-02-10 English
Please find attached herewith the announcement with respect to Circular Resolution passed by the Board of Director of the Company on 05/02/2026
Board/Management Information Classification · 100% confidence The document is a notification under Regulation 30 of the SEBI Listing Regulations about the reconstitution of various board committees by appointing a new member. It is an announcement of changes in the company's board committee composition, not a full report or financial statement. The document length is short (1939 characters) and contains no financial data or detailed report content. Therefore, it fits the category of Board/Management Information (MANG).
2026-02-05 English
Disclosure of material issue
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, 2015. It informs about the reconstitution of various board committees by appointing a new member. The content focuses on changes in board committee memberships rather than financial results, audit reports, or other report types. The document length is short (1939 characters) and it is an announcement of management/board changes. Therefore, it fits the category of Board/Management Information (MANG).
2026-02-05 English
Sadhana Nitro Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve the Unaudited Standalone ....
Board/Management Information Classification · 95% confidence The document is a notification to stock exchanges about an upcoming Board Meeting scheduled for February 10, 2026. It mentions the agenda to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2025. The document also references compliance with insider trading regulations and the closure of the trading window. The document is short (2221 characters) and serves as an intimation or announcement rather than containing the actual financial results or detailed report. Therefore, it is an announcement related to board/management activities, specifically a Board Meeting notice, which fits the category of Board/Management Information (MANG).
2026-02-04 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges about an upcoming Board Meeting scheduled for February 10, 2026. The purpose of the meeting includes consideration and approval of unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The document also references compliance with insider trading regulations and trading window closure. The document is short (2221 characters) and serves as an intimation or announcement of a board meeting rather than containing the actual financial results or detailed report. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER), but rather a Regulatory Filing (RNS) as it is a general regulatory announcement about the meeting and upcoming results.
2026-02-04 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-02-04 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.